Shahryar Rizvi, Author at NFCR

Shahryar Rizvi

Michael Hall Named 2020 Sjöberg Prize Recipient

Michael N. Hall, Ph.D., the National Foundation for Cancer Research’s (NFCR) 2017 Szent-Györgyi Prize for Progress in Cancer Research winner, and David Sabatini, M.D., Ph.D., were named winners of the 2020 Sjöberg Prize “for their discovery of the target of rapamycin and the mammalian target of rapamycin, and their roles…...

Read more

2019 Szent-Györgyi Prize Invite

2019 Szent-Györgyi Prize will be awarded to Steven A. Rosenberg, M.D., Ph.D for revolutionizing the field of cancer immunotherapy When:  Saturday, April 27th, 2019 6:00 pm Where:  The National Press Club 529 14th Street, NW Washington, DC 20045 Dress Code: Cocktail Attire For information on parking, metro routes and directions to the venue…...

Read more

CT109

New potential therapies to treat Colorectal and Pancreatic Cancer...

Read more

YIV-906

First-in-class botanical cancer platform drug to treat Liver Cancer...

Read more

IL-24

Cancer Terminator Viruses for the targeted therapy of a diverse array of aggressive tumor types such as Brain and Skin Cancer...

Read more

PDZ1i

A novel small-molecule inhibitor of a specific cancer-promoting protein to treat Liver Cancer...

Read more

ST-001

A unique nano-delivery system to enable intravenous (IV) delivery of water-insoluble cancer drug to treat Lymphoma and Lung Cancer...

Read more